Voltaren Arthritis Pain Gel Recalled for Improper Storage Conditions
Family Dollar Stores is recalling Voltaren Arthritis Pain Gel 20G distributed April–June 2022 due to storage temperature deviations that may affect product effectiveness.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: No illnesses or injuries have been reported. This is an FDA Class II recall due to a manufacturing process deviation (improper storage conditions), classified as a precautionary measure to preserve product quality and efficacy.
Plain-English summary
Family Dollar Stores, LLC is recalling Voltaren Arthritis Pain Gel 20G that was distributed at specific Family Dollar store locations between April 30, 2022 and June 10, 2022 (SKU 998708). The recall is due to Good Manufacturing Practice (CGMP) deviations—specifically, the product was stored outside appropriate temperature conditions during distribution.
Storage temperature deviations can affect the stability and efficacy of topical medications. Consumers who purchased this product during the affected timeframe should check if they still have any remaining stock.
If you have this recalled product, stop using it and contact Family Dollar Stores or the FDA with any questions or to report concerns. Additional information is available from your local Family Dollar store or the FDA.
The recalled product
- Product
- VOLTAREN ARTHRITIS PAIN GEL 20G distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Topical Pain Relief
- Hazard
- temperature-excursion
- product-degradation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 998708
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27